Flashpoint Medica LLC – Trademark Portfolio

Entity Type: 16

Flashpoint Medica LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 5 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include FLASHPOINT MEDICA. The owner is based in New York, NY.

2nd Floor

158 West 29th Street

New York, NY 10001

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Flashpoint Medica LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (5 filings)

Advertising; business management; business administration; office functions

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Flashpoint Medica LLC have?

Flashpoint Medica LLC has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 cancelled.

What trademark classes does Flashpoint Medica LLC file in?

Flashpoint Medica LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.

What are Flashpoint Medica LLC's most well-known trademarks?

Flashpoint Medica LLC's registered trademark portfolio includes well-known marks such as FLASHPOINT MEDICA. These are among 1 currently registered trademark in the portfolio.

What is Flashpoint Medica LLC's trademark registration success rate?

Flashpoint Medica LLC has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.